← FDA DRUG APPROVALS

FDA ANDA · ANDA088031

HYDROFLUMETHIAZIDE

Sponsor: WATSON LABS

APPLICATION
ANDA088031
TYPE
ANDA
LATEST ACTION
1986-07-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDROFLUMETHIAZIDEDiscontinued
HYDROFLUMETHIAZIDE 50MG · TABLET · ORAL

Approval history

1986-07-02Manufacturing (CMC) · Supplement 3AP
1986-07-02Manufacturing (CMC) · Supplement 1AP
1986-07-02Manufacturing (CMC) · Supplement 2AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →